CN105004684B - Nickel-IgE chelate as well as preparation method and application thereof - Google Patents
Nickel-IgE chelate as well as preparation method and application thereof Download PDFInfo
- Publication number
- CN105004684B CN105004684B CN201510411520.6A CN201510411520A CN105004684B CN 105004684 B CN105004684 B CN 105004684B CN 201510411520 A CN201510411520 A CN 201510411520A CN 105004684 B CN105004684 B CN 105004684B
- Authority
- CN
- China
- Prior art keywords
- ige
- nickel
- chelates
- dilution buffer
- chromatographic column
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000013522 chelant Substances 0.000 title claims abstract description 14
- 238000002360 preparation method Methods 0.000 title claims abstract description 13
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 claims abstract description 199
- 229910052759 nickel Inorganic materials 0.000 claims abstract description 91
- 229910001453 nickel ion Inorganic materials 0.000 claims abstract description 13
- 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 claims abstract description 4
- 238000000034 method Methods 0.000 claims description 99
- 239000000243 solution Substances 0.000 claims description 96
- 239000013024 dilution buffer Substances 0.000 claims description 68
- 239000007788 liquid Substances 0.000 claims description 63
- 102000004190 Enzymes Human genes 0.000 claims description 60
- 108090000790 Enzymes Proteins 0.000 claims description 60
- 239000003480 eluent Substances 0.000 claims description 40
- 238000002965 ELISA Methods 0.000 claims description 30
- 238000001962 electrophoresis Methods 0.000 claims description 28
- 239000000463 material Substances 0.000 claims description 28
- 210000004369 blood Anatomy 0.000 claims description 26
- 239000008280 blood Substances 0.000 claims description 26
- 238000006243 chemical reaction Methods 0.000 claims description 25
- 239000003292 glue Substances 0.000 claims description 25
- 238000010790 dilution Methods 0.000 claims description 23
- 239000012895 dilution Substances 0.000 claims description 23
- 102000004169 proteins and genes Human genes 0.000 claims description 23
- 108090000623 proteins and genes Proteins 0.000 claims description 23
- 230000001900 immune effect Effects 0.000 claims description 16
- 239000000872 buffer Substances 0.000 claims description 15
- 239000003153 chemical reaction reagent Substances 0.000 claims description 14
- 238000000746 purification Methods 0.000 claims description 14
- 238000000862 absorption spectrum Methods 0.000 claims description 12
- 239000011248 coating agent Substances 0.000 claims description 12
- 238000000576 coating method Methods 0.000 claims description 12
- 238000001095 inductively coupled plasma mass spectrometry Methods 0.000 claims description 12
- 238000011068 loading method Methods 0.000 claims description 12
- 238000000605 extraction Methods 0.000 claims description 11
- 238000000918 plasma mass spectrometry Methods 0.000 claims description 11
- 238000000502 dialysis Methods 0.000 claims description 10
- 238000011049 filling Methods 0.000 claims description 10
- 238000011010 flushing procedure Methods 0.000 claims description 10
- 239000000945 filler Substances 0.000 claims description 9
- 238000010612 desalination reaction Methods 0.000 claims description 8
- 239000012154 double-distilled water Substances 0.000 claims description 8
- 238000011067 equilibration Methods 0.000 claims description 8
- 230000009870 specific binding Effects 0.000 claims description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- 239000003795 chemical substances by application Substances 0.000 claims description 7
- 229920002401 polyacrylamide Polymers 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 5
- 238000001042 affinity chromatography Methods 0.000 claims description 4
- 238000004090 dissolution Methods 0.000 claims description 4
- 239000002504 physiological saline solution Substances 0.000 claims description 4
- 229910019142 PO4 Inorganic materials 0.000 claims description 3
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims description 3
- 239000010452 phosphate Substances 0.000 claims description 3
- 238000010170 biological method Methods 0.000 claims description 2
- 150000002500 ions Chemical class 0.000 claims 2
- 230000001939 inductive effect Effects 0.000 claims 1
- 238000001819 mass spectrum Methods 0.000 claims 1
- 238000001514 detection method Methods 0.000 abstract description 42
- 210000002966 serum Anatomy 0.000 abstract description 8
- VEQPNABPJHWNSG-UHFFFAOYSA-N Nickel(2+) Chemical compound [Ni+2] VEQPNABPJHWNSG-UHFFFAOYSA-N 0.000 abstract 1
- 229940088598 enzyme Drugs 0.000 description 55
- 238000004140 cleaning Methods 0.000 description 42
- 239000000523 sample Substances 0.000 description 42
- 238000005406 washing Methods 0.000 description 33
- 210000002381 plasma Anatomy 0.000 description 30
- 239000013642 negative control Substances 0.000 description 19
- 239000000758 substrate Substances 0.000 description 17
- 230000000694 effects Effects 0.000 description 16
- 238000005119 centrifugation Methods 0.000 description 13
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 12
- 239000000499 gel Substances 0.000 description 12
- 239000013641 positive control Substances 0.000 description 12
- 229920001223 polyethylene glycol Polymers 0.000 description 10
- 238000001556 precipitation Methods 0.000 description 10
- 230000008859 change Effects 0.000 description 9
- 238000010828 elution Methods 0.000 description 9
- 235000018102 proteins Nutrition 0.000 description 9
- 239000000284 extract Substances 0.000 description 8
- 239000007790 solid phase Substances 0.000 description 8
- 238000010521 absorption reaction Methods 0.000 description 7
- 239000007853 buffer solution Substances 0.000 description 7
- 238000011109 contamination Methods 0.000 description 7
- 230000003248 secreting effect Effects 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- 108090000526 Papain Proteins 0.000 description 6
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 6
- 239000004365 Protease Substances 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 239000002253 acid Substances 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 6
- 229910001385 heavy metal Inorganic materials 0.000 description 6
- 239000012160 loading buffer Substances 0.000 description 6
- 229940055729 papain Drugs 0.000 description 6
- 235000019834 papain Nutrition 0.000 description 6
- 235000020183 skimmed milk Nutrition 0.000 description 6
- 238000011160 research Methods 0.000 description 5
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 4
- 241000283725 Bos Species 0.000 description 4
- 206010028980 Neoplasm Diseases 0.000 description 4
- 239000002202 Polyethylene glycol Substances 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 238000002523 gelfiltration Methods 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 229910052751 metal Inorganic materials 0.000 description 4
- 239000002184 metal Substances 0.000 description 4
- 210000002345 respiratory system Anatomy 0.000 description 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M sodium bicarbonate Substances [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 4
- 230000005469 synchrotron radiation Effects 0.000 description 4
- 229910021642 ultra pure water Inorganic materials 0.000 description 4
- 238000000108 ultra-filtration Methods 0.000 description 4
- 238000005199 ultracentrifugation Methods 0.000 description 4
- 239000012498 ultrapure water Substances 0.000 description 4
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 3
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 3
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 3
- 241000040710 Chela Species 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 3
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical group O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 3
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 3
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 3
- 229940098773 bovine serum albumin Drugs 0.000 description 3
- -1 by eat Chemical compound 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 238000007865 diluting Methods 0.000 description 3
- 229910000397 disodium phosphate Inorganic materials 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000007789 gas Substances 0.000 description 3
- 238000001426 native polyacrylamide gel electrophoresis Methods 0.000 description 3
- 229910017604 nitric acid Inorganic materials 0.000 description 3
- 229910052698 phosphorus Inorganic materials 0.000 description 3
- 239000011574 phosphorus Substances 0.000 description 3
- 239000012266 salt solution Substances 0.000 description 3
- 238000009938 salting Methods 0.000 description 3
- 238000007789 sealing Methods 0.000 description 3
- 230000028327 secretion Effects 0.000 description 3
- 238000001228 spectrum Methods 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 239000003053 toxin Substances 0.000 description 3
- 231100000765 toxin Toxicity 0.000 description 3
- GIJIKFKGLZGENN-UHFFFAOYSA-N (4-ethoxyphenyl) 4-butoxycarbonyloxybenzoate Chemical compound C1=CC(OC(=O)OCCCC)=CC=C1C(=O)OC1=CC=C(OCC)C=C1 GIJIKFKGLZGENN-UHFFFAOYSA-N 0.000 description 2
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 239000000427 antigen Substances 0.000 description 2
- 102000036639 antigens Human genes 0.000 description 2
- 108091007433 antigens Proteins 0.000 description 2
- UDSAIICHUKSCKT-UHFFFAOYSA-N bromophenol blue Chemical compound C1=C(Br)C(O)=C(Br)C=C1C1(C=2C=C(Br)C(O)=C(Br)C=2)C2=CC=CC=C2S(=O)(=O)O1 UDSAIICHUKSCKT-UHFFFAOYSA-N 0.000 description 2
- 231100000357 carcinogen Toxicity 0.000 description 2
- 239000003183 carcinogenic agent Substances 0.000 description 2
- 210000003022 colostrum Anatomy 0.000 description 2
- 235000021277 colostrum Nutrition 0.000 description 2
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 2
- 238000012921 fluorescence analysis Methods 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 238000009616 inductively coupled plasma Methods 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 244000000010 microbial pathogen Species 0.000 description 2
- 239000011259 mixed solution Substances 0.000 description 2
- 210000004400 mucous membrane Anatomy 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 239000000376 reactant Substances 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000000741 silica gel Substances 0.000 description 2
- 229910002027 silica gel Inorganic materials 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 239000003643 water by type Substances 0.000 description 2
- DWNBOPVKNPVNQG-LURJTMIESA-N (2s)-4-hydroxy-2-(propylamino)butanoic acid Chemical compound CCCN[C@H](C(O)=O)CCO DWNBOPVKNPVNQG-LURJTMIESA-N 0.000 description 1
- ALLIZEAXNXSFGD-UHFFFAOYSA-N 1-methyl-2-phenylbenzene Chemical group CC1=CC=CC=C1C1=CC=CC=C1 ALLIZEAXNXSFGD-UHFFFAOYSA-N 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 241000991587 Enterovirus C Species 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 108010020056 Hydrogenase Proteins 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 108010044467 Isoenzymes Proteins 0.000 description 1
- 239000007836 KH2PO4 Substances 0.000 description 1
- VHJLVAABSRFDPM-IMJSIDKUSA-N L-1,4-dithiothreitol Chemical compound SC[C@H](O)[C@@H](O)CS VHJLVAABSRFDPM-IMJSIDKUSA-N 0.000 description 1
- 229910003307 Ni-Cd Inorganic materials 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 108091000080 Phosphotransferase Proteins 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 206010037423 Pulmonary oedema Diseases 0.000 description 1
- 102400001107 Secretory component Human genes 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 239000008186 active pharmaceutical agent Substances 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000010056 antibody-dependent cellular cytotoxicity Effects 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 239000004327 boric acid Substances 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 239000011852 carbon nanoparticle Substances 0.000 description 1
- 238000003115 checkerboard titration Methods 0.000 description 1
- 230000009920 chelation Effects 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 239000005515 coenzyme Substances 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 239000003398 denaturant Substances 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000019621 digestibility Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 230000005670 electromagnetic radiation Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 210000003979 eosinophil Anatomy 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000002189 fluorescence spectrum Methods 0.000 description 1
- 238000001502 gel electrophoresis Methods 0.000 description 1
- 238000001641 gel filtration chromatography Methods 0.000 description 1
- 230000000762 glandular Effects 0.000 description 1
- 238000000673 graphite furnace atomic absorption spectrometry Methods 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 231100000567 intoxicating Toxicity 0.000 description 1
- 230000002673 intoxicating effect Effects 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 231100000518 lethal Toxicity 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000003563 lymphoid tissue Anatomy 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 239000011785 micronutrient Substances 0.000 description 1
- 235000013369 micronutrients Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000002808 molecular sieve Substances 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 210000004493 neutrocyte Anatomy 0.000 description 1
- 150000002816 nickel compounds Chemical class 0.000 description 1
- 238000010606 normalization Methods 0.000 description 1
- 230000001473 noxious effect Effects 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 238000011017 operating method Methods 0.000 description 1
- 230000008816 organ damage Effects 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 239000003973 paint Substances 0.000 description 1
- 102000020233 phosphotransferase Human genes 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 230000036470 plasma concentration Effects 0.000 description 1
- 238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000006916 protein interaction Effects 0.000 description 1
- 239000012460 protein solution Substances 0.000 description 1
- 208000005333 pulmonary edema Diseases 0.000 description 1
- 208000005069 pulmonary fibrosis Diseases 0.000 description 1
- 230000001698 pyrogenic effect Effects 0.000 description 1
- 238000004451 qualitative analysis Methods 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000006479 redox reaction Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 210000005000 reproductive tract Anatomy 0.000 description 1
- 208000023504 respiratory system disease Diseases 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 210000003079 salivary gland Anatomy 0.000 description 1
- 239000012723 sample buffer Substances 0.000 description 1
- 238000009738 saturating Methods 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 1
- UCIYAWPLDHZJJL-UHFFFAOYSA-M sodium;2-[2-[bis(carboxymethyl)amino]ethyl-(carboxymethyl)amino]acetic acid;hydrogen carbonate Chemical compound [Na+].OC([O-])=O.OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O UCIYAWPLDHZJJL-UHFFFAOYSA-M 0.000 description 1
- 229910001256 stainless steel alloy Inorganic materials 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000009182 swimming Effects 0.000 description 1
- 230000001360 synchronised effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- 210000001138 tear Anatomy 0.000 description 1
- 230000000451 tissue damage Effects 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 238000004876 x-ray fluorescence Methods 0.000 description 1
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
Abstract
The invention discloses a nickel-IgE chelate and a preparation method and application thereof, wherein the nickel-IgE chelate is formed by chelating nickel ions and IgE through sulfydryl or/and cysteine residues. The invention establishes a qualitative and quantitative detection method of nickel-IgE chelate so as to quantitatively detect the application of the nickel-IgE chelate in evaluating the nickel pollution degree of one region. The condition of nickel pollution of people in a region can be indirectly reflected by quantitatively detecting the nickel-IgE chelate in the serum of people in the region, so that the nickel pollution degree of the region can be indirectly reflected. The nickel-IgE chelate quantitative detection method established by the invention has the advantages that the accuracy is greatly improved, and the repeatability of detection is greatly improved.
Description
Technical field
The present invention relates to detection field, more specifically to a kind of nickel-IgE chelates and its preparation method and application.
Background technology
IgE is mainly produced by mucosa-associated lymphoid tissue, and wherein most is as synthesized by gastrointestinal lymphoid sample tissue, less
Part is synthesized by respiratory tract, salivary gland and genital tract mucosal tissue.Nursing period puerpera's glandular tissue contains a large amount of IgE and produces cell,
These cells are essentially from stomach and intestine.In the mankind, also a small amount of IgE comes from marrow.People birth after 4~June start synthesize IgE, 4
Content reaches adult levels in~12 years old serum, and 10% or so of the total Ig of serotype IgE, about 5~6 days half-life period.IgE have IgE1 and
Two subclass of IgE2.IgE1 is primarily present in serum, and the chain molecular weights of 85%, α 1 for accounting for IgE in serum are 56kD；IgE2 master
It is present in exocrine secretion, small part exists with serotype IgE, and the chains of 15%, α 2 for accounting for IgE in serum lack hinge area,
Molecular weight is 52kD.There are the forms such as the dimer being covalently attached to by J chains or tripolymer outside IgE demonomerizations form in serum.
Secretory IgE is made up of the binary and secretory component of J connections, is primarily present in colostrum, saliva, tear, gastro-intestinal Fluid, branch gas
Pipe secretion etc. is in exocrine secretion, is the most important factor of mucous membrane local immunity, secretory IgE by with corresponding pathogenic microorganism
(such as poliovirus) combines, and prevents it to be adsorbed onto on permissive cell, secretory IgE can also neutralize a toxin such as comma bacillus
Toxin and large intestine bar toxin etc..Neonate be susceptible to suffer from respiratory tract, alimentary infection may with IgE synthesize deficiency it is relevant.Chronic branch gas
The scorching breaking-out of pipe and the reduction of secretory IgE also have certain relation.Secretory IgE can be passed to baby by puerpera by colostrum, this
A kind of and important natural passive immunity.Eosinophil, neutrophil leucocyte and Expression of Macrophages Fc α R, serotype list
Body IgE can mediate opsonophagocytosis and ADCC to act on.In addition, secretory IgE has immune exclusion function, i.e. secretory IgE combines
The pyrogenic substances that substantial amounts of soluble antigen and normal intestinal flora or pathogenic microorganism are discharged in diet, prevent them from entering
Enter blood.
It is well known that nickel (Nickel, Ni) and human body is healthy closely bound up, it is that human body maintains health institute required first
Trace element, it is present in a variety of hydrogenases, is catalyzed the redox reaction of hydrogen, participates in the synthesis of a variety of zymoproteins and thin
The metabolism of intracellular hormone and pigment, there is the absorption for promoting iron and the growth of red blood cell, kinase formed coenzyme, enhancing insulin,
The effects such as hypoglycemic, protection angiocarpy, so if human body lacks nickel, can cause the generation of disease.But the fact is being lived
In, due to environmental pollution, nickel is seldom lacked in human body, the content of opposite nickel is usually excessive, frequently results in the generation of disease, even
Threat to life.
Nickel common are noxious metals as one kind, among being widely used in living, producing, including production coin, jewelry, nickel
Stainless steel alloy, manufacture Ni-Cd batteries etc., it is closely bound up with the life of people.With the development of science and technology people are using nickel as urging
Among production of the agent for producing carbon nano-particle, influence of the nickel for the mankind is further deepened.For general population,
Nickel mainly by eat, drink into, contact etc. mode take in nickel, certain smoking is also an important channel.Research is found, excessive
Nickel can cause body many places tissue and organ damage, cause the generation of a variety of diseases, including respiratory disease (pneumonia, branch gas
Guan Yan, pulmonary fibrosis, asthma, pulmonary edema etc.), angiocardiopathy, kidney trouble, disease of skin etc., or even also result in tumour
Generation.
Epidemiologic data shows that the worker of Long Term Contact nickel, it is suffered from the probability of tumor in respiratory system and greatly increased, and
It is also greatly increased because of the lethal probability of tumor in respiratory system.Animal model, external model experiment, it was also found that nickel can induce it is swollen
The generation of knurl.Nineteen ninety, international cancer research institution (International Agency for Research on Cancer,
IARC) using nickel compound as first kind carcinogen (Group 1), using metallic nickel as 2B class carcinogens (Group
2B).It can be seen that the health of nickel serious threat human body.
It is in close relations between nickel and multiple proteins, it can be combined with multiple proteins, suppress the activity of multiple protein enzyme.
With going deep into nickel toxicity research, people gradually recognize that the interaction of nickel and albumen is played the part of emphatically during its intoxicating
The role wanted, it is considered to be understand the key point of the toxicity mechanism of nickel, therefore, the research to nickel and protein interaction is just
Seem ever more important.And the mechanism now concerning nickel and protein effect is only tip of the iceberg, also many protein and nickel it
Between relation it is not clear, thus strengthen it is most important for the relation between nickel and protein.
The content of the invention
For nickel contamination it is serious the problem of, it is an object of the invention to provide a kind of nickel-IgE chelates and its preparation side
Method, and the qualitative and quantitative analysis method of nickel-IgE chelates is established, so that quantitative detection nickel-IgE chelates are evaluating a ground
The application of area's nickel contamination degree.This can be reflected indirectly by nickel-IgE chelates in one regional crowd's serum of quantitative detection
Regional crowd by nickel contamination situation, so as to reflecting this regional nickel contamination degree indirectly.
The technical solution adopted for the present invention to solve the technical problems is：A kind of nickel-IgE chelates are provided, nickel ion with
IgE is formed by sulfydryl or/and cysteine residues chelating.
The present invention also provides a kind of preparation method of above-mentioned nickel-IgE chelates, comprises the following steps：
A) nickel and IgE chelatropic reaction：Add in the IgE that purification comes from the IgE of human body or is recombinated according to biological method
Enter nickel ion and carry out chelatropic reaction, obtain reaction solution；
B the extraction of nickel-IgE chelates) is purified：Using immune-affinity chromatography, unreacted IgE in reaction solution is removed
And unnecessary nickel ion, produce nickel-IgE chelates.
Wherein, step B described in external synthetic method) it is specific as follows：
(1) sample dissolution：To passing through step A) physiological saline is added in obtained reaction solution answers nickel-IgE chelates
It is molten；
(2) chromatographic column is balanced：The pipeline of chromatographic column is rinsed using dilution buffer, loading in chromatographic column can be special with IgE
The filler that the opposite sex combines, after filling post, it is continuing with dilution buffer balance chromatographic column；
(3) loading：After column equilibration is chromatographed, with sample in dilution buffer dilution step (1), then upper prop, IgE is with filling out
Material specific binding；
(4) elute：Chromatographic column to baseline is rinsed using dilution buffer to balance, then using 0.05-0.1mol/L phosphorus
Acid salt solution is eluted, and obtains eluent I；
(5) collect：Collect eluent I；
(6) dialyse：By the eluent of the collection in step (5), bag filter is filled, uses ddH2O dialysis desalinations, change water three times
Afterwards, 4 DEG C of dialysed overnights, sample is collected；
(7) chromatographic column is balanced：Using new chromatographic column, with dilution buffer flushing line, load energy in the chromatographic column
With the filler of nickel specific binding, chromatographic column is balanced with dilution buffer again after filling post；
(8) loading：After column equilibration is chromatographed, with sample in dilution buffer dilution step (6), then upper prop；
(9) elute：Chromatographic column to baseline is rinsed using dilution buffer to balance, then using 0.5-1.0mol/L phosphoric acid
Salting liquid is eluted, and obtains eluent II；
(10) collect：Collect eluent II；
(11) dialyse：By the eluent of the collection in step (10), bag filter is filled, uses ddH2O dialysis desalinations, change water three times
Afterwards, 4 DEG C of dialysed overnights, sample is collected, produces nickel-IgE chelates.
Wherein, the preparation method of above-mentioned nickel-IgE chelates, in addition to step C)：Identification to nickel-IgE chelates；
Wherein, step C) in it is specific as follows：
(1) glue bed is prepared：Glue bed is prepared using one kind in Ago-Gel, polyacrylamide gel as medium；
(2) it is loaded：Take step B) in the obtained nickel-IgE chelates of extraction purification, add dilution buffer, and mix, so
After be loaded onto in sample cell；
(3) electrophoresis：Electrophoresis plate is connected, carries out electrophoresis；
(4) detect：Nickeliferous protein band is found out on glue bed, the protein band is taken out and dissolved, is then used again
ELISA method or ICP-MS methods or AAS methods detect whether containing nickel and detected the content of nickel.
The present invention also provides a kind of nickel-IgE chelates described above and is preparing the examination of nickel-IgE chelates in detection human body
Application in agent or kit.
The present invention, which also provides, a kind of comprises at least kit of the nickel-IgE chelates described above as standard items.
Preferably, coating buffer is also included in the kit, the coating buffer contains capture IgE material or the thing of capture nickel
Matter.
The present invention also provides a kind of method for quantitatively detecting nickel-IgE chelates, with the above-mentioned nickel-IgE chelas of known content
Compound is detected as standard items using a pair of samples of following methods：ELISA, enzyme linked immunological and atomic absorption light
Spectrum combined techniques, enzyme linked immunological are combined with inductivity coupled plasma mass spectrometry combined techniques, purifying nickel-IgE chelates with enzyme linked immunological
Method, purifying nickel-IgE chelates and atomic absorption spectrum combined techniques, purifying nickel-IgE chelates and inductively coupled plasma matter
Compose combined techniques, electrophoresis and enzyme linked immunological or atomic absorption spectrum or inductivity coupled plasma mass spectrometry combined techniques.
Implement nickel-IgE chelates of the present invention and its preparation method and application, have the advantages that：
1. the present invention synthesizes nickel-IgE chelates in vitro first；
2. present invention firstly provides nickel-IgE chelates can be used for prepare detection blood sample in nickel-IgE chelates reagent or
Application in kit.
3. the present invention establishes the method for qualitative and quantitative detection of nickel-IgE chelates, so as to quantitative detection nickel-IgE chelates
Evaluating the application of a regional nickel contamination degree.Can be with by nickel-IgE chelates in one regional crowd's serum of quantitative detection
Reflect situation of this regional crowd by nickel contamination indirectly, so as to reflect this regional nickel contamination degree indirectly.The present invention establishes
Nickel-IgE chelates quantitative detecting method its degree of accuracy greatly improve, and the repeatability of detection is greatly enhanced.
Brief description of the drawings
Fig. 1 is the non denatured electrophoretic band figure of nickel-IgE chelates of the present invention；
Fig. 2 is the synchrotron radiation X line fluorescence analysis figure of the electrophoretic band of nickel-IgE chelates of the present invention.
Embodiment
Below, with reference to embodiment, the present invention is described further：
Unless otherwise indicated, the laboratory operating procedures being related to are the conventional step in this area to the present invention, agents useful for same, material
Material as following cited, do not include in the present invention come be reagent commonly used in the art or can be by mode purchased in market
Obtain：
Phosphate solution is 0.05-0.1mol/L Na2HPO4Solution or 0.5-1mol/L Na2HPO4Solution；
Extracts reagent is (using PEG methods) such as PEG solution, borate buffer solutions；
Glue bed medium is one kind in Ago-Gel, polyacrylamide gel；
IgE material purchase is captured from the model Abcam ab171396 of Amy victory Science and Technology Ltd. rabbit Anti-
IgE antibody；Wherein, material, anti-IgE antibodies, the anti-IgE antibodies of the present invention with IgE specific bindings are capture IgE
Material；
The material for capturing nickel is the model RK14419 of Guangzhou Ran Ke companies production anti-nickel antibody；Wherein, institute of the present invention
State the material specifically bound with nickel, Ni resists, anti-Ni antibody, anti-nickel antibody are the material for capturing nickel；
Enzyme labelled antibody is one kind in the antibody containing the enzymes such as horseradish peroxidase, alkaline phosphatase mark；
Substrate is methyl biphenyl amine (TMB) solution；
Cleaning solution is to contain KH2PO40.2mg/ml、Na2HPO4·12H2O 2.90mg/ml、NaCl8.0mg/ml、KCl
0.2mg/ml, 0.5%Tween-20 pH are 7.4 0.15M PBS solutions；
Confining liquid is 1%-5% bovine serum albumin(BSA)s or skimmed milk power；
Dilution buffer is Na containing 1.5mg/mL2CO3、2.93mg/ml NaHCO3PH be 9.6 0.05M carbonate delay
Fliud flushing；
Enzyme labelled antibody is HRP enzyme labelled antibodies；
Terminate liquid is：By 21.7ml 2M H2SO4It is settled to 200ml ddH2In O；
Eluent is the 0.1mol/L Tris-HCL buffer solutions that the PH containing papain is 8.0；
Acidulant is nitric acid；
Sample-loading buffer is to contain 1M Tris-HCl (pH 6.8) 15.5mL, 1% bromophenol blue 2.5mL, ddH2It is O7mL, sweet
Propylhomoserin 25mL Sample buffer (5X)；
Electrophoretic buffer is the ddH that 3mg/ml containing Tris, glycine 14.4mg/ml PH are 6.82O solution；
The present invention provides a kind of nickel-IgE chelates, nickel ion and IgE by sulfydryl or/and cysteine residues chelate and
Into.
The present invention also provides a kind of preparation method of nickel-IgE chelates, comprises the following steps：
A) nickel and IgE chelatropic reaction：Nickel ion is added in the IgE in people source and carries out chelatropic reaction, obtains reaction solution；
B the extraction of nickel-IgE chelates) is purified：Using immune-affinity chromatography, unreacted IgE in reaction solution is removed
And unnecessary nickel ion, nickel-IgE chelates are produced, are comprised the following steps that：
(1) sample dissolution：To passing through step A) physiological saline is added in obtained reaction solution answers nickel-IgE chelates
It is molten；
(2) chromatographic column is balanced：The pipeline of chromatographic column is rinsed using dilution buffer, loading in chromatographic column can be special with IgE
The filler that the opposite sex combines, after filling post, it is continuing with dilution buffer balance chromatographic column；It is described to be filled out with what IgE was specifically bound
Expect for silica gel or resin containing anti-IgE antibodies；
(3) loading：After column equilibration is chromatographed, with sample in dilution buffer dilution step (1), then upper prop, IgE is with filling out
Material specific binding；
(4) elute：Chromatographic column to baseline is rinsed using dilution buffer to balance, then using 0.05-0.1mol/L phosphorus
Acid salt solution is eluted, and obtains eluent I；
(5) collect：Collect eluent I；
(6) dialyse：By the eluent of the collection in step (5), bag filter is filled, uses ddH2O dialysis desalinations, change water three times
Afterwards, 4 DEG C of dialysed overnights, sample is collected；
(7) chromatographic column is balanced：Using new chromatographic column, with dilution buffer flushing line, load energy in the chromatographic column
With the filler of nickel specific binding, chromatographic column is balanced with dilution buffer again after filling post；It is described to be filled out with what nickel was specifically bound
Expect for silica gel or resin containing anti-nickel antibody；
(8) loading：After column equilibration is chromatographed, with sample in dilution buffer dilution step (6), then upper prop；
(9) elute：Chromatographic column to baseline is rinsed using dilution buffer to balance, then using 0.5-1.0mol/L phosphoric acid
Salting liquid is eluted, and obtains eluent II；
(10) collect：Collect eluent II；
(11) dialyse：By the eluent of the collection in step (10), bag filter is filled, with 2 liters of ddH2O dialysis desalinations, change water
After three times, 4 DEG C of dialysed overnights, sample is collected, produces nickel-IgE chelates；
C) to the identification of nickel-IgE chelates, comprise the following steps that：
(1) glue bed is prepared：Glue bed is prepared using one kind in Ago-Gel, polyacrylamide gel as medium；
(2) it is loaded：Take step B) in the obtained nickel-IgE chelates of extraction purification, add dilution buffer, and mix, so
After be loaded onto in sample cell；
(3) electrophoresis：Electrophoresis plate is connected, carries out electrophoresis；
(4) detect：Nickeliferous protein band is found out on glue bed, the protein band is taken out and dissolved, is then used again
ELISA method or ICP-MS methods or AAS methods detect whether containing nickel and detected the content of nickel.
The present invention, which also provides, a kind of comprises at least kit of the nickel-IgE chelates described above as standard items.
Preferably, coating buffer is also included in the kit, the coating buffer contains capture IgE material or the thing of capture nickel
Matter.
In the present invention, can realize the kit of the object of the invention can list following several, but be not limited to this.
The kit of nickel-IgE chelates in a kind of detection blood sample, including the coating buffer of the material containing capture IgE, closing
Liquid, cleaning solution, the material for capturing nickel as secondary antibody, enzyme labelled antibody, substrate, terminate liquid, dilution buffer, positive control,
Negative control etc..
The kit of nickel-IgE chelates in a kind of detection blood sample, including the coating buffer of the material containing capture IgE, closing
Liquid, cleaning solution, eluent, positive control, negative control etc..
The kit of nickel-IgE chelates in a kind of detection blood sample, including the coating buffer of the material containing capture IgE, closing
Liquid, cleaning solution, eluent, acidulant, hydrogen peroxide, positive control, negative control etc..
The kit of nickel-IgE chelates in a kind of detection blood sample, including as extracts reagent needed for IgE in purifying blood plasma,
Redissolve liquid, the coating buffer containing the material for capturing nickel, confining liquid, cleaning solution, enzyme labelled antibody, substrate, terminate liquid, dilution buffer
Liquid, positive control, negative control etc..
The kit of nickel-IgE chelates in a kind of detection blood sample, including as extracts reagent needed for IgE in purifying blood plasma,
Redissolve liquid, positive control, negative control etc..
The kit of nickel-IgE chelates in a kind of detection blood sample, including as extracts reagent needed for IgE in purifying blood plasma,
Redissolve liquid, acidulant, hydrogen peroxide, positive control, negative control etc..
The kit of nickel-IgE chelates in a kind of detection blood sample, including as IgE extracts reagent, glue in purifying blood plasma
Bed medium, redissolve liquid, sample-loading buffer, dissolve liquid needed for protein band nickeliferous on glue bed, containing the material for capturing nickel
Coating buffer, confining liquid, cleaning solution, enzyme labelled antibody, substrate, terminate liquid, dilution buffer, positive control, negative control etc..
The kit of nickel-IgE chelates in a kind of detection blood sample, including as extracts reagent needed for IgE in purifying blood plasma,
Glue bed medium, redissolve liquid, sample-loading buffer, dissolve liquid, positive control, negative control needed for protein band nickeliferous on glue bed
Deng.
The kit of nickel-IgE chelates in a kind of detection blood sample, including as extracts reagent needed for IgE in purifying blood plasma,
Glue bed medium, redissolve liquid, sample-loading buffer, liquid needed for nickeliferous protein band on dissolving glue bed, acidulant, hydrogen peroxide,
Positive control, negative control etc..
In above-mentioned several kits, the positive control is standard items, that is, is chelated with IgE chelates or the chela of heavy metal nickel
Closing has the BSA chelates of heavy metal nickel；The negative control is the dilution buffer for not containing standard items.
Mentioned reagent box is used for the IgE for detecting chelating nickel, to improve the accuracy of detection, repeatability, and is allowed in clinic
In be promoted.
The present invention also provides a kind of method for quantitatively detecting nickel-IgE chelates, with the above-mentioned nickel-IgE chelas of known content
Compound is detected as standard items using a pair of samples of following methods：ELISA, enzyme linked immunological and atomic absorption light
Spectrum combined techniques, enzyme linked immunological are combined with inductivity coupled plasma mass spectrometry combined techniques, purifying nickel-IgE chelates with enzyme linked immunological
Method, purifying nickel-IgE chelates and atomic absorption spectrum combined techniques, purifying nickel-IgE chelates and inductively coupled plasma matter
Compose combined techniques, electrophoresis and enzyme linked immunological or atomic absorption spectrum or inductivity coupled plasma mass spectrometry combined techniques.In the present invention,
Having of can listing of method with detection nickel-IgE chelates is following several, but is not limited to following several.
Wherein, the reagent used in the above-mentioned method for quantitatively detecting nickel-IgE chelates is as follows：
Method one：ELISA (ELISA method) detects nickel-IgE chelates, detects in accordance with the following steps：
1) IgE material will can be captured, as anti-IgE antibodies (anti-IgE Ab) are coated on solid phase carrier：It is slow with dilution
Fliud flushing to diluting 1000-8000 times, adds anti-IgE Ab in elisa plate micropore, 4 DEG C of overnight 16-18 hours, or 37 DEG C of water-baths
1-3 hours, store refrigerator；
2) blood plasma is taken from the circulatory system, makees measuring samples, 1000rmp centrifugation 5-8 minutes, centrifugation discards precipitation；
3) close：Dilution buffer is removed, and is washed with cleaning solution, is waited after the completion of washing, is added with 1%-5% oxen
As confining liquid, 37 DEG C are placed 1 hour, remove confining liquid, and are washed with cleaning solution, are washed for seralbumin or skimmed milk power
After the completion of washing, elisa plate places 1-2 hours in 36.5-37.5 DEG C；
4) add measuring samples, and incubate：Measuring samples, the nickel-IgE chelates with known content added in step 2)
Make standard items；Measuring samples are diluted to 10-40 times with dilution buffer, added in micropore, 37 DEG C of effect 1-2 hours；
5) material of nickel can be captured by adding, and be incubated：Measuring samples are removed, and are washed with cleaning solution, it is to be washed
After the completion of washing, addition is diluted to 5000-40000 times of anti-Ni Ab with dilution buffer, 37 DEG C of effect 1-2 hours, makes anti-Ni
Metal nickel reactant on Ab and IgE forms antigen antibody complex；
6) enzyme conjugates incubates：Anti- nickel antibody is removed, and is washed with cleaning solution, is waited after the completion of washing, is added with dilute
Release the enzyme labelled antibody of buffer solution dilution, the concentration for making the enzyme labelled antibody of dilution is 2 μ g/mL, 37 DEG C of effect 1-2 hours, make its with
Enzyme labelled antibody reacts；
7) substrate incubates：Enzyme labelled antibody is removed, and is washed with cleaning solution, is waited after the completion of washing, addition substrate, 37 DEG C
Lucifuge acts on 30 minutes；
8) terminating reaction：Terminate liquid is added dropwise to each micropore；
9) wavelength 405nm is taken, after adding terminate liquid, elisa plate is placed on ELIASA and detected, reads measuring samples respectively
With the OD values of standard items, by drawing standard curve, the content for trying to achieve measuring samples (also can directly pass through without using ELIASA
Colour developing situation carries out qualitative detection).
This method utilizes ELISA principles, can extract the specific IgE in blood plasma, the IgE tops extracted
Divide and be chelated with heavy metal nickel, and the nickel on the IgE of this part is captured by anti-nickel antibody, afterwards can be again by horseradish peroxidase
The antibody of the enzymes such as enzyme, alkaline phosphatase mark captures (the antibody nonrecognition coating protein), and the antibody in capture is in developer
And in the presence of terminate liquid, OD values can be read under instrument, and do not contain the IgE of chelated mineral nickel, then will not be by anti-nickel
Specific antibody is captured, and the antibody that will not be also marked with enzymes such as horseradish peroxidase, alkaline phosphatases is captured, and used
Metallic nickel (negative control group result is feminine gender) is not contained in reagent, thus works as read OD value results and is shown as positive yet
When, you can prove to detect the metallic nickel chelated on IgE.
Method two：Enzyme linked immunological is pressed with atomic absorption spectrum combined techniques (ELISA method+AAS methods) detection nickel-IgE chelates
Detected according to following steps：
1) IgE material will can be captured, as anti-IgE antibodies (anti-IgE Ab) are coated on solid phase carrier：It is slow with dilution
Anti- IgE Ab are diluted to 1000-8000 times by fliud flushing, are added in elisa plate micropore, 4 DEG C of overnight 16-18 hours, or 37 DEG C of water-baths
1-3 hours, store refrigerator；
2) blood plasma is taken from the circulatory system, makees measuring samples, 1000rpm centrifugation 5-8 minutes, centrifugation discards precipitation；
3) close：Dilution buffer is removed, and is washed with cleaning solution, is waited after the completion of washing, is added with 1%-5% oxen
As confining liquid, 37 DEG C are placed 1 hour, remove confining liquid, and are washed with cleaning solution, are washed for seralbumin or skimmed milk power
After the completion of washing, elisa plate places 1-2 hours in 36.5-37.5 DEG C；
4) add measuring samples, and incubate：Measuring samples, the nickel-IgE chelates with known content added in step 2)
Make standard items；Measuring samples are diluted to 10-40 times with dilution buffer, added in micropore, 37 DEG C of effect 1-2 hours；
5) elute：Measuring samples are removed, and are washed with cleaning solution, are waited after the completion of washing, eluent are added, at 37 DEG C
Lower elution 1-3 hours.
6) detect：Sample, chelated in Atomic Absorption Spectrometer detection in the nickel on IgE, and paint from the micropore of elisa plate
Standard curve processed, readout value；
This method combines atomic absorption spectrum (AAS) principle on the basis of utilizing ELISA principles, utilizes atomic absorption spectrum
Instrument detection is chelated in the nickel on IgE, due to only containing IgE in solution, and any heavy metal (negative control is free of in agents useful for same
Group result is feminine gender), result will not be interfered, thus when the result read is shown as the positive, you can prove detection
Go out the metallic nickel chelated on IgE.
Method three：Enzyme linked immunological and inductivity coupled plasma mass spectrometry combined techniques (ELISA method+ICP-MS methods) detection nickel-
IgE chelates detect in accordance with the following steps：
1) IgE material will can be captured, as anti-IgE antibodies (anti-IgE Ab) are coated on solid phase carrier：It is slow with dilution
Anti- IgE Ab are diluted to 1000-8000 times by fliud flushing, are added in elisa plate micropore, 4 DEG C of overnight 16-18 hours, or 37 DEG C of water-baths
1-3 hours, store refrigerator；
2) blood plasma is taken from the circulatory system, makees measuring samples, 1000rmp centrifugation 5-8 minutes, centrifugation discards precipitation；
3) close：Dilution buffer is removed, and is washed with cleaning solution, is waited after the completion of washing, is added with 1%-5% oxen
As confining liquid, 37 DEG C are placed 1 hour, remove confining liquid, and are washed with cleaning solution, are washed for seralbumin or skimmed milk power
After the completion of washing, elisa plate places 1-2 hours in 36.5-37.5 DEG C；
4) add measuring samples, and incubate：Measuring samples, the nickel-IgE chelates with known content added in step 2)
Make standard items；Measuring samples are diluted to 10-40 times with dilution buffer, added in micropore, 37 DEG C of effect 1-2 hours；
5) elute：Measuring samples are removed, and are washed with cleaning solution, are waited after the completion of washing, eluent are added, at 37 DEG C
Lower elution 1-3 hours.
6) it is acidified：Acidulant is added in solution in step 5) to be acidified solution, sealing overnight, is thoroughly acidified,
Hydrogen peroxide is added, and heats and catches up with acid；
7) detect：0.5ml liquid is taken from the solution of the elisa plate of step 6), in icp mses
Lower detection chelates the nickel in IgE, and draws standard curve, readout value.
This method is on the basis of using ELISA principles, with reference to sense coupled plasma mass spectrometry (ICP-MS) principle, electricity consumption
Sense couple plasma mass spectrometer detection is chelated in the nickel on IgE, due to only containing IgE in solution, and is free of in agents useful for same
Any heavy metal (negative control group result is feminine gender), will not interfere to result, thus works as read result and be shown as
When positive, you can prove to detect the metallic nickel chelated on IgE.
Method four：Purifying nickel-IgE chelates chelate with enzyme linked immunological combined techniques (method of purification+ELISA method) detection nickel-IgE
Thing, detect in accordance with the following steps：
1) IgE is extracted from blood plasma：Using the polyethylene glycol PEG precipitation method or ultracentrifugation or molecule ultrafiltration or gel filtration
The methods of from the IgE in blood plasma extraction purification blood, and IgE is redissolved in solution, obtains IgE solution；
2) anti-Ni Ab are coated on solid phase carrier：Anti- Ni Ab are diluted to 5000-40000 times with dilution buffer,
Add in elisa plate micropore, 4 DEG C of overnight 16-18 hours, or 37 DEG C of water-bath 1-3 hours, store refrigerator；
3) close：Dilution buffer is removed, and is washed with cleaning solution, is waited after the completion of washing, is added with 1%-5% oxen
As confining liquid, 37 DEG C are placed 1 hour, remove confining liquid, and are washed with cleaning solution, are washed for seralbumin or skimmed milk power
After the completion of washing, elisa plate places 1-2 hours in 36.5-37.5 DEG C；
4) add measuring samples, and incubate：Sampled from the solution of step 1), make measuring samples；With the nickel of known content-
IgE chelates make standard items；Measuring samples are diluted to 10-40 times with dilution buffer, added in micropore, 37 DEG C of effect 1-2
Hour；
5) enzyme conjugates incubates：The measuring samples in step 4) are removed, and are washed with cleaning solution, treat that washing is completed
Afterwards, the enzyme labelled antibody that addition is diluted with dilution buffer, the concentration for making the enzyme labelled antibody of dilution are 2 μ g/mL, 37 DEG C of effect 1-2
Hour, it is reacted with enzyme labelled antibody；
6) substrate incubates：Enzyme labelled antibody is removed, and is washed with cleaning solution, is waited after the completion of washing, addition substrate, 37 DEG C
Lucifuge acts on 30 minutes；
7) terminating reaction：Terminate liquid is added dropwise to each micropore；
8) wavelength 405nm is taken, after adding terminate liquid, elisa plate is placed on ELIASA and detected, reads measuring samples respectively
With the OD values of standard items, by drawing standard curve, the content for trying to achieve measuring samples (also can directly pass through without using ELIASA
Colour developing situation carries out qualitative detection).
Method five：Purifying nickel-IgE chelates are detected in blood sample with atomic absorption spectrum combined techniques (method of purification+AAS methods)
Nickel-IgE chelates, are detected in accordance with the following steps：
1) IgE is extracted from blood plasma：Using the polyethylene glycol PEG precipitation method or ultracentrifugation or molecule ultrafiltration or gel filtration
The methods of from the IgE in blood plasma extraction purification blood, and IgE is redissolved in solution, obtains IgE solution；
2) detect：Sample in the solution obtained from step 1), chelated in Atomic Absorption Spectrometer detection in the nickel on IgE,
And standard curve is drawn, readout value.
Method six：Purifying nickel-IgE chelates and inductivity coupled plasma mass spectrometry combined techniques (method of purification+ICP-MS methods)
Nickel-IgE chelates are detected, are detected in accordance with the following steps：
1) IgE is extracted from blood plasma：Using the polyethylene glycol PEG precipitation method or ultracentrifugation or molecule ultrafiltration or gel filtration
The methods of from the IgE in blood plasma extraction purification blood, and IgE is redissolved in solution, obtains IgE solution；
2) it is acidified：Sampled in the solution obtained from step 1), add acidulant (such as nitric acid) in the solution and solution is carried out
Acidifying, sealing overnight, thoroughly acidifying, add hydrogen peroxide, and heat and catch up with acid；
3) detect：0.5ml liquid is taken in the solution obtained from step 2), is detected under icp mses
Chelate in the nickel on IgE, and draw standard curve, readout value.
Method seven：Electrophoresis and ELISA or atomic absorption spectrography (AAS) or inductivity coupled plasma mass spectrometry combined techniques
(electrophoresis-ELISA method/AAS methods/ICP-MS methods) detects nickel-IgE chelates, detects in accordance with the following steps：
1) IgE is extracted from blood plasma：Using the polyethylene glycol PEG precipitation method or ultracentrifugation or molecule ultrafiltration or gel filtration
The methods of from the IgE in blood plasma extraction purification blood, and IgE is redissolved in solution, obtains IgE solution；
2) glue bed is prepared：Selection Ago-Gel or polyacrylamide gel or SDS- polyacrylamide gels as needed
Deng medium is used as, glue bed is conventionally prepared；
3) it is loaded：The μ L of solution 8 for taking step 1) to obtain add 2 μ L sample-loading buffers, mix, of short duration centrifugation；(pay attention to herein
Step can not boil)
4) electrophoresis：Electrophoresis plate is connected, is separated by electrophoresis；
5) detect：The protein band containing nickel is found out on glue bed, the band is taken out, after treatment by the albumen one
Band is dissolved among liquid, is then utilized respectively ELISA or ICP-MS again or AAS detects the nickel content being dissolved in liquid.In addition, also
IgE isoelectric point, molecular weight and content of the method detection chelating nickel etc. can be utilized.
IgE in method seven can be come out with a variety of Methods For Purifications (such as supercentrifugation or HPLC or
Gel-filtration chromatography or gel electrophoresis or ELISA method etc.), IgE out will be purified and redissolved in solution, taken a certain amount of
IgE, using electric charge shifting principle, carry out electrophoresis (electrophoresis, EP), (can be as needed using not in gel slab
Same medium) on can run out of different bands according to molecular weight, isoelectric point etc. are different, search out the respective strap rich in nickel, will be solidifying
Protein in glue is redissolved in solution, you can to detect related IgE content at a particular wavelength, can also utilize ELISA,
The principles such as AAS, ICP-MS detect to chelate in the nickel content on IgE, due to only containing IgE in solution, and in agents useful for same not
Containing any heavy metal (negative control group result is feminine gender), result will not be interfered, thus work as read result and show
For the positive when, you can prove to detect the metallic nickel chelated on IgE.
Embodiment 1：The preparation method of nickel-IgE chelates, comprises the following steps：
A) nickel and IgE chelatropic reaction：Nickel ion is added in the IgE in people source and carries out chelatropic reaction, obtains reaction solution；
Preparation of reagents：
1) borate buffer solution (0.01M)：Weigh 0.31g boric acid to be dissolved in 400ml ultra-pure waters, adjusted with 0.1M NaOH
PH to 9.0, is settled to 500mL.
2) IgE solution：Weigh 4.0mg IgE to be dissolved in 4.0mL 0.01M pH9.0 borate buffer solutions, fully vibrate molten
Solution, it is configured to 1.0mg/mL protein solution；
3) EDTA-NaHCO3 mixed solutions：Weigh EDTA2H2O 1.86g、NaHCO316.8g is dissolved in 900mL ultra-pure waters
In, it is settled to 1000ml, autoclaving, room temperature preservation with 1.0M NaOH adjustment pH to 8.0；
4) ITCBE is bought from Japanese colleague's chemistry institute, article No. M030；
5) bag filter is purchased from Bioshop Inc, molecular cut off 14000.
The chelation step of nickel-IgE chelates：
1) processing of bag filter：Bag filter is put into 500ml EDTA-NaHCO3In mixed solution, 10min is boiled；Incline
Abandon EDTA/NaHCO3Liquid, gently rinsed with ultra-pure water, then 10min is boiled with 500ml 5mmol/L EDTA solution；Discard and boil
Liquid is boiled, is thoroughly cleaned with ultra-pure water, adds 4 DEG C of ultra-pure water immersion bag filter overnight.In use, putting on one's gloves, bag filter is taken out,
With its surfaces externally and internally of ultra-pure water cleaning down；
2) 2.0mg ITCBE are taken to be dissolved in 2ml DMSO；
3) 4.0mg IgE are taken to be dissolved in 4.0ml borate buffer solutions；
4) liquid for slowly preparing step 2) is added in the IgE solution that step 3) is prepared, and is shaken when being added dropwise, is placed in temperature
Spend for 25 DEG C, rotating speed is to react 24h in 100r/min shaking table, then with bag filter dialysis 24h, removes what is do not combined with IgE
ITCBE；
5) liquid obtained by step 4) is adjusted into pH value to 7.0 with 1mol/L HCl, is then slowly gradually added dropwise 80 μ l's
1mmol/L nickel ion solution, vibrated when being added dropwise, in case nickel ion precipitates albuminous degeneration；
6) solution obtained by step 5) is placed in temperature as 25 DEG C, rotating speed is to react 2h in 100r/min shaking table, with saturating
Analysis bag carries out dialysis 24h；
7) liquid after step 6) is dialysed preserves in -20 DEG C of packing, obtains reaction solution.
B the extraction of nickel-IgE chelates) is purified：Using immune-affinity chromatography, removing reaction solution, (i.e. step 7) obtains
Reaction solution) in unreacted IgE and unnecessary nickel ion, produce nickel-IgE chelates, comprise the following steps that：
(1) sample dissolution：Physiological saline is added into the reaction solution obtained by step 7) answers nickel-IgE chelates
It is molten；
(2) chromatographic column is balanced：The pipeline of chromatographic column is rinsed using dilution buffer, loading in chromatographic column can be special with IgE
The filler that the opposite sex combines, after filling post, it is continuing with dilution buffer balance chromatographic column；
(3) loading：After column equilibration is chromatographed, with sample in dilution buffer dilution step (1), then upper prop, IgE is with filling out
Material specific binding；
(4) elute：Chromatographic column to baseline is rinsed using dilution buffer to balance, then using 0.05-0.1mol/L phosphorus
Acid salt solution is eluted, and obtains eluent I；
(5) collect：Collect eluent I；
(6) dialyse：By the eluent of the collection in step (5), bag filter is filled, uses ddH2O dialysis desalinations, change water three times
Afterwards, 4 DEG C of dialysed overnights, sample is collected；
(7) chromatographic column is balanced：Using new chromatographic column, with dilution buffer flushing line, load energy in the chromatographic column
With the filler of nickel specific binding, chromatographic column is balanced with dilution buffer again after filling post；
(8) loading：After column equilibration is chromatographed, with sample in dilution buffer dilution step (6), then upper prop；
(9) elute：Chromatographic column to baseline is rinsed using dilution buffer to balance, then using 0.5-1.0mol/L phosphoric acid
Salting liquid is eluted, and obtains eluent II；
(10) collect：Collect eluent II；
(11) dialyse：By the eluent of the collection in step (10), bag filter is filled, with 2 liters of ddH2O dialysis desalinations, change water
After three times, 4 DEG C of dialysed overnights, sample is collected, produces nickel-IgE chelates；
C) to the identification of nickel-IgE chelates, comprise the following steps that：
(1) glue bed is prepared：Glue bed is prepared using Ago-Gel as medium；
(2) it is loaded：Take step B) in the obtained nickel-IgE chelates of 8 μ L extraction purifications, add 2 μ L sample-loading buffers, and
Mix, be then loaded onto in sample cell；
(3) electrophoresis：Electrophoresis plate is connected, electrophoretic buffer is added and carries out electrophoresis；In electrophoresis process, electric current is 22mA constant currents,
Environment temperature is 4 DEG C；Electrophoresis to bromophenol blue stops electrophoresis when moving to glue bottom；
(4) detect：Nickeliferous protein band is found out on glue bed, the protein band is taken out and dissolved, is then used again
ELISA method or ICP-MS methods or AAS methods detect whether containing nickel and detected the content of nickel.
D) testing result
(1) content of beary metal in graphite furnace atomic absorption spectrometry (AAS) Preliminary Determination IgE：It the results are shown in Table 1
Table 1 is content of beary metal (μ g/L) in IgE
| Sample name | Ni(μg/L) |
| IgE | 181.64 |
| (NH4)2SO4 | 0.249 |
| N.S | 0.002 |
| N.S | 0 |
(2) electrophoresis result：
Wherein, Fig. 1 is the non denatured electrophoretic band figure of nickel-IgE chelates of the present invention.
Native polyacrylamide gel electrophoresis (Native-PAGE) or for active electrophoresis be be added without SDS and dredge
Under conditions of the denaturants such as base ethanol, polyacrylamide gel electrophoresis is carried out to the protein for keeping activity, is usually used in the mirror of enzyme
Fixed, Isozyme Analysis and purification.Not plus SDS native polyacrylamide gel electrophoresis can make large biological molecule in electrophoresis process
Middle its natural shape of holding and electric charge, their separation are made according to the difference of its electrophoretic mobility and the molecular sieve of gel
With, thus higher resolution ratio can be obtained, especially remain to keep the large biological molecule such as protein and enzyme after electrophoretic separation
Bioactivity, therefore left lane M is denaturation Marker, is served only for detecting, does not mark effect, swimming lane 4 for IgE bar
Band.
(3) Synchrotron Radiation X-Ray Fluorescence Anal ysis：
4W1 " of the SRXRF analyses of micronutrient levels in BEPC (BEPC) is synchronous in protein band
Completed on radiation bunch.Beam current energy is 2.2GeV, beam intensity 100mA in storage rings.Sample mobile station (TSA200
Type, Beijing are stood upright Han Guang companies) can be moved up under the stepper motor driving that computer controls along X, Y two-dimensional square with change into
Penetrate facula position, moving step length 0.0025mm.From the X ray that electromagnetic radiation goes out by Si (Li) detector (PGT Inc.LS
30143-DS) detect, probe is with incident SR lines copline and being mutually perpendicular to, and away from sample irradiation point 20mm, signal is divided with PGT multiple tracks
Analyzer (MCA4000) obtains output.Sample, regulation launching spot (1mmx3mm) are excited with 11.5keV monochromatic synchrotron radiation light
Position is allowed to be in band one end, and in 300s minute, hot spot uniformly slowly moves along band always, at the end of counting
Hot spot moves on to the band other end.Along electrophoresis direction a spectrum is taken per 1mm.Using AX IL software data processings, and with deriving from
Air and the Ar signal peaks of content constant carry out normalization to other element peaks, to offset beam intensity change to signal strength
Caused influence.Measure the fluorescence Spectra of quantitative criterion dry glue film in the same way under the same conditions.
Fig. 2 is the synchrotron radiation X line fluorescence analysis figure of the electrophoretic band of nickel-IgE chelates of the present invention, horizontal in figure
Coordinate is protein band position, and ordinate is each metal energy of the band (content) value.
A kind of determination of the testing conditions for the method for quantitatively detecting nickel-IgE chelates of the present invention：
1. the determination of the optimum diluting multiple of anti-IgE antibodies, anti-nickel antibody best effort concentration and blood plasma
Step is as follows：
(1) it is 1 according to anti-IgE Ab and the mass volume ratio of dilution buffer by anti-IgE Ab dilution buffers:
1000、1:2000、1:4000、1:8000 are diluted, and add in elisa plate micropore, anti-IgE Ab are coated in into solid phase carrier
On, each concentration is coated with three rows, and 4 DEG C are stayed overnight 18 hours；
(2) dilution buffer is removed, and is washed with cleaning solution, is waited after the completion of washing, is made with 2% bovine serum albumin(BSA)
For confining liquid, 37 DEG C are placed 1 hour, remove confining liquid, and washed with cleaning solution；
(3) measuring samples are 1 by measuring samples and the mass volume ratio of dilution buffer:10、1:20、1:40 progress are dilute
Release, add in micropore, according to above-mentioned coated anti-IgE Ab concentration, being separately added into for the anti-IgE Ab of same concentration is different dilute
Degree of releasing blood plasma, 37 DEG C act on 1 hour；
(4) measuring samples are removed, and are washed with cleaning solution, are waited after the completion of washing, add anti-Ni Ab, anti-Ni Ab are pressed
Anti- Ni Ab and the mass volume ratio of dilution buffer are 1:5000、1:10000、1:20000、1:40000 are diluted, according to
Each identical anti-IgE Ab, diluted plasma concentration, the anti-Ni Ab of various concentrations respectively add 2 holes, and 37 DEG C act on 1 hour, make anti-Ni
Metal nickel reactant on Ab and IgE；
(5) enzyme labelled antibody selects most suitable working concentration, i.e. 2 μ g/mL, removes anti-Ni antibody, and is washed with cleaning solution,
Wait after the completion of washing, addition dilution buffer dilutes HRP enzyme labelled antibodies, and 37 DEG C act on 1 hour, make HRP enzyme labelled antibodies and nickel-
IgE chelates react；
(6) enzyme labelled antibody is removed, and is washed with cleaning solution, is waited after the completion of washing, adds substrate, 37 DEG C of lucifuge effects
30 minutes；
(7) terminate liquid is added dropwise to each micropore；
(8) wavelength 405nm is taken, after adding terminate liquid, elisa plate is placed on ELIASA and detected, reads each hole OD respectively
Value.According to each hole OD value numerical value, anti-IgE Ab, anti-Ni Ab best effort concentration and blood plasma optimum diluting multiple are selected.
Simultaneously using made standard items as positive control in experiment, anti-IgE Ab+ closings+anti-Ni Ab+ enzymes mark+bottom is selected
Thing (being not added with measuring samples) is used as negative control 1；Anti- IgE Ab+ closings+blood plasma+enzyme mark+substrate (being not added with anti-Ni Ab) is made
For negative control 2；Anti- IgE Ab+ closings+enzyme mark+substrate (being not added with measuring samples and anti-Ni Ab) are used as negative control 3；It is anti-
IgE Ab+ closings+blood plasma+anti-Ni Ab+ substrates (i.e. not enzyme-added mark) are used as negative control 4；Closing+blood plasma+anti-Ni Ab+ enzyme marks
+ substrate (being not added with anti-IgE Ab captures IgE) is used as blank control 1；Only add substrate as blank control 2 and PBS as blank
Control 3.Testing result is shown in Table 2-3.
Table 2：Checkerboard titration method determines anti-IgE Ab, anti-Ni Ab best effort concentration and blood plasma optimal dilution times
Several data (each data are all average value)
Table 3：ELISA positive controls and negative control ELISA testing results
Shown by table 2-3 data, we can see that the dilution factor of anti-IgE antibodies is 1:2000th, dilution rate of blood plasma 1:
10th, the anti-dilution factors of Ni are 1:When 10000, OD values are maximum, so selecting the concentration corresponding to this value as best effort concentration.
2. quantitatively detect in the method for nickel-IgE chelates eluent best effort concentration and elution time in method two, three
Determination
Step is as follows：(1) it is coated with：Anti- Ni Ab are diluted to 10000 times (mass volume ratios) with dilution buffer, added
In elisa plate micropore, 37 DEG C of water-baths 3 hours, refrigerator is stored；
(2) close：Dilution buffer is removed, and is washed with cleaning solution, is waited after the completion of washing, it is pure with 2% ox blood
As confining liquid, 37 DEG C are placed 1 hour albumen, remove confining liquid, and washed with cleaning solution；
(3) confining liquid is removed, and is washed with cleaning solution, is waited after the completion of washing, addition is diluted with dilution buffer
Enzyme labelled antibody, enzyme labelled antibody are diluted to concentration as 2 μ g/mL, and 37 DEG C act on 2 hours, it is reacted with anti-Ni Ab；
(4) eluent is prepared：By papain with pH 8.0,0.1mol/L Tris-HCI buffers into
100ng/ml, add 37 DEG C of incubation 30min of 1mmol/L dithiothreitol (DTT)s (DTT)；
(5) enzyme labelled antibody is removed, eluent is diluted with dilution buffer, makes papain in eluent
The ratio between concentration and the concentration of enzyme labelled antibody are 1:80、1:40、1:20、1:10、1:5 (wherein each concentration makees 3 multiple holes), respectively
1h, 2h, 3h are eluted at a temperature of being positioned over 37 DEG C；
(6) eluent is removed, and is washed with cleaning solution, is waited after the completion of washing, adds substrate, 37 DEG C of lucifuge effects 30
Minute；
(7) terminate liquid is added dropwise to each micropore；
(8) 405nm wavelength is taken, after adding terminate liquid, elisa plate is placed on ELIASA and detected, reads every group of OD respectively
Value, by compared with PBS group, comparing the optimum concentration and elution time of eluent, concrete outcome is referring to table 4.
Table 4：ELISA eluent best effort concentration and elution time determine
We are it can be found that when the concentration of the papain in eluent and the ratio between the concentration of enzyme labelled antibody from table 4
=1:When 20, each group OD values are below other several groups, illustrate that the concentration elution effect is optimal (i.e. by ELISA hole walls
With reference to anti-Ni Ab- enzyme marks compound elution degree reach maximum, thus OD values are minimum)；And elution time either 1h, 2h,
3h, each group OD value changes are little, it is seen that with the extension of time, enzyme activity gradually weakens, in the case where enzyme concentration is constant,
Digestibility can not be improved by extending digestion time, so the elution time of eluent all may be used for 1-3h in this experiment.
Application Example 1
Take using the nickel-IgE chelates in 100 parts of sample blood plasma of ELISA method detection, follow the steps below detection：
ELISA (ELISA method) detects nickel-IgE chelates, detects in accordance with the following steps：
1) anti-IgE Ab are coated on solid phase carrier：Anti- IgE Ab are diluted to 2000 times with dilution buffer, added
In elisa plate micropore, 37 DEG C of water-baths 1 hour, refrigerator is stored；
2) blood plasma is taken from the circulatory system, makees measuring samples, 1000rmp centrifugation 5-8 minutes, centrifugation discards precipitation；
3) close：Dilution buffer is removed, and is washed with cleaning solution, is waited after the completion of washing, adds 2% bovine serum albumin
It is white be used as confining liquid, 37 DEG C of placements 1 hour, remove confining liquid, and washed with cleaning solution, after the completion of washing, elisa plate in
37 DEG C are placed 1 hour；
4) add measuring samples, and incubate：Measuring samples, the nickel-IgE chelates with known content added in step 2)
Make standard items；Measuring samples are diluted to 10 times with dilution buffer, added in micropore, 37 DEG C act on 1 hour；
5) material of nickel can be captured by adding, and be incubated：Measuring samples are removed, and are washed with cleaning solution, it is to be washed
After the completion of washing, addition dilution buffer dilutes 5000 times, and 37 DEG C act on 1 hour, make anti-Ni Ab and the metallic nickel on IgE anti-
Should；
6) enzyme conjugates incubates：Anti- nickel antibody is removed, and is washed with cleaning solution, is waited after the completion of washing, is added with dilute
The HRP enzyme labelled antibodies of buffer solution dilution are released, 37 DEG C act on 1 hour, it is reacted with enzyme labelled antibody；
7) substrate incubates：Enzyme labelled antibody is removed, and is washed with cleaning solution, is waited after the completion of washing, addition substrate, 37 DEG C
Lucifuge acts on 30 minutes；
8) terminating reaction：Terminate liquid is added dropwise to each micropore；
9) it is 405nm to take wavelength, after adding terminate liquid, elisa plate is placed on ELIASA and detected, and reads treat sample respectively
Product OD values (also directly can carry out qualitative detection) without using ELIASA by the situation that develops the color, and specific detected value is as shown in table 5.
Table 5：The ELISA testing results of nickel-IgE chelates in 100 parts of blood samples
| Numbering | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 |
| OD405 | 0.36 | 0.623 | 0.398 | 0.495 | 0.501 | 0.669 | 0.437 | 0.323 | 0.393 | 0.342 |
| Numbering | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 |
| OD405 | 0.572 | 0.48 | 0.614 | 0.772 | 0.689 | 0.706 | 0.678 | 0.309 | 0.363 | 0.512 |
| Numbering | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 |
| OD405 | 0.347 | 0.396 | 0.441 | 0.411 | 0.536 | 0.556 | 0.378 | 0.603 | 0.316 | 0.372 |
| Numbering | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40 |
| OD405 | 0.81 | 0.753 | 0.796 | 0.788 | 0.456 | 0.586 | 0.38 | 0.656 | 0.755 | 0.766 |
| Numbering | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 |
| OD405 | 0.587 | 0.64 | 0.742 | 0.466 | 0.344 | 0.627 | 0.635 | 0.642 | 0.466 | 0.613 |
| Numbering | 51 | 52 | 53 | 54 | 55 | 56 | 57 | 58 | 59 | 60 |
| OD405 | 0.501 | 0.419 | 0.765 | 0.681 | 0.445 | 0.504 | 0.684 | 0.457 | 0.561 | 0.801 |
| Numbering | 61 | 62 | 63 | 64 | 65 | 66 | 67 | 68 | 69 | 70 |
| OD405 | 0.799 | 0.397 | 0.562 | 0.755 | 0.383 | 0.701 | 0.78 | 0.739 | 0.688 | 0.723 |
| Numbering | 71 | 72 | 73 | 74 | 75 | 76 | 77 | 78 | 79 | 80 |
| OD405 | 0.495 | 0.471 | 0.505 | 0.321 | 0.813 | 0.614 | 0.513 | 0.552 | 0.753 | 0.787 |
| Numbering | 81 | 82 | 83 | 84 | 85 | 86 | 87 | 88 | 89 | 90 |
| OD405 | 0.403 | 0.323 | 0.596 | 0.633 | 0.826 | 0.689 | 0.304 | 0.355 | 0.532 | 0.543 |
| Numbering | 91 | 92 | 93 | 94 | 95 | 96 | 97 | 98 | 99 | 100 |
| OD405 | 0.703 | 0.739 | 0.567 | 0.347 | 0.643 | 0.544 | 0.301 | 0.571 | 0.348 | 0.823 |
Application Example 2
Using in enzyme linked immunological and minute mark this blood sample of atomic absorption spectrum combined techniques (ELISA method+AAS methods) detection 100
Nickel-IgE chelates, are detected in accordance with the following steps：
1) IgE material will can be captured, as anti-IgE antibodies (anti-IgE Ab) are coated on solid phase carrier：It is slow with dilution
Anti- IgE Ab are diluted to 2000 times by fliud flushing, are added in elisa plate micropore, and 4 DEG C are stayed overnight 18 hours；
2) blood plasma is taken from the circulatory system, makees measuring samples, 1000rmp centrifugation 5-8 minutes, centrifugation discards precipitation；
3) close：Dilution buffer is removed, and is washed with cleaning solution, is waited after the completion of washing, it is pure to add 2% ox blood
Albumen or skimmed milk power are as confining liquid, and 37 DEG C are placed 1 hour, remove confining liquid, and are washed with cleaning solution, and washing is completed
Afterwards, elisa plate is placed 1 hour in 37 DEG C；
4) add measuring samples, and incubate：Measuring samples, the nickel-IgE chelates with known content added in step 2)
Make standard items；Measuring samples are diluted to 10 times with dilution buffer dilution, added in micropore, 37 DEG C act on 1 hour；
5) elute：Measuring samples are removed, and are washed with cleaning solution, are waited after the completion of washing, it is dense to add papain
The eluent for 100ng/ml is spent, elutes 1-3 hours；
6) detect：Sample from the micropore of elisa plate, chelated in Atomic Absorption Spectrometer detection in the nickel on IgE, detection
Value is as shown in table 6.
Table 6：The AAS testing results of nickel-IgE chelates in 100 parts of blood samples
Application Example 3
100 minute marks are detected using enzyme linked immunological and inductivity coupled plasma mass spectrometry combined techniques (ELISA method+ICP-MS methods)
Nickel-IgE chelate contents in this blood sample, are detected in accordance with the following steps：
1) IgE material will can be captured, as anti-IgE antibodies (anti-IgE Ab) are coated on solid phase carrier：It is slow with dilution
Anti- IgE Ab are diluted to 2000 times by fliud flushing, are added in elisa plate micropore, and 4 DEG C are stayed overnight 18 hours；
2) taking 100 parts of standard blood samples, 1000rmp centrifugation 5-8 minutes, centrifugation discards precipitation as measuring samples；
3) close：Dilution buffer is removed, and is washed with cleaning solution, is waited after the completion of washing, it is pure to add 2% ox blood
As confining liquid, 37 DEG C are placed 1 hour albumen, remove confining liquid, and are washed with cleaning solution, after the completion of washing, elisa plate
Placed 1 hour in 37 DEG C；
4) add measuring samples, and incubate：Measuring samples, the nickel-IgE chelates with known content added in step 2)
Make standard items；Measuring samples are diluted to 10 times with dilution buffer, added in micropore, 37 DEG C act on 1 hour；
5) elute：Measuring samples are removed, and are washed with cleaning solution, are waited after the completion of washing, it is dense to add papain
The eluent for 100ng/ml is spent, elutes 1-3 hours；
6) it is acidified：Add nitric acid in solution in step 5) to be acidified solution, overnight, thoroughly acidifying, adds for sealing
Enter hydrogen peroxide, and heat and catch up with acid；
7) detect：Sampled in the solution obtained from step 6), under icp mses detection chelate in
IgE nickel, detected value are as shown in table 7.
Table 7：The ICP-MS testing results of nickel-IgE chelates in 100 parts of blood samples
It will be apparent to those skilled in the art that technical scheme that can be as described above and design, make other various
Corresponding change and deformation, and all these changes and deformation should all belong to the protection domain of the claims in the present invention
Within.
Claims (6)
- A kind of 1. nickel-IgE chelates, it is characterised in that nickel ion and IgE by sulfydryl or/and cysteine residues chelate and Into；The preparation method of the nickel-IgE chelates, comprises the following steps：A) nickel and IgE chelatropic reaction：Nickel is added in purification comes from the IgE of human body or the IgE according to biological method restructuring Ion carries out chelatropic reaction, obtains reaction solution；B) the extraction of nickel-IgE chelates：Using immune-affinity chromatography, unreacted IgE and unnecessary is removed in reaction solution Nickel ion, produce nickel-IgE chelates；The step B) it is specific as follows：(1) sample dissolution：To passing through step A) physiological saline is added in obtained reaction solution redissolves nickel-IgE chelates；(2) chromatographic column is balanced：The pipeline of chromatographic column is rinsed using dilution buffer, loading in chromatographic column can be with IgE specificity With reference to filler, fill post after, be continuing with dilution buffer balance chromatographic column；(3) loading：After column equilibration is chromatographed, with sample in dilution buffer dilution step (1), then upper prop, IgE are special with filler The opposite sex combines；(4) elute：Chromatographic column to baseline is rinsed using dilution buffer to balance, then using 0.05-0.1mol/L phosphate Solution is eluted, and obtains eluent I；(5) collect：Collect eluent I；(6) dialyse：By the eluent of the collection in step (5), bag filter is filled, uses ddH2O dialysis desalinations, after changing water three times, 4 DEG C Dialysed overnight, collect sample；(7) chromatographic column is balanced：Using new chromatographic column, with dilution buffer flushing line, energy and nickel are loaded in the chromatographic column The filler of specific binding, chromatographic column is balanced with dilution buffer again after filling post；(8) loading：After column equilibration is chromatographed, with sample in dilution buffer dilution step (6), then upper prop；(9) elute：Chromatographic column to baseline is rinsed using dilution buffer to balance, it is then molten using 0.5-1.0mol/L phosphate Liquid is eluted, and obtains eluent II；(10) collect：Collect eluent II；(11) dialyse：By the eluent of the collection in step (10), bag filter is filled, uses ddH2O dialysis desalinations, after changing water three times, 4 DEG C dialysed overnight, sample is collected, produces nickel-IgE chelates.
- 2. nickel-IgE chelates according to claim 1, the step B of its preparation method) also include step C afterwards)：It is right The identification of nickel-IgE chelates；Wherein, step C) in it is specific as follows：(1) glue bed is prepared：Glue bed is prepared using one kind in Ago-Gel, polyacrylamide gel as medium；(2) it is loaded：Take step B) in the obtained nickel-IgE chelates of purifying, add dilution buffer, and mix, be then loaded onto In sample cell；(3) electrophoresis：Electrophoresis plate is connected, carries out electrophoresis；(4) detect：Nickeliferous protein band is found out on glue bed, the protein band is taken out and dissolved, then uses ELISA again Method or ICP-MS methods or AAS methods detect whether containing nickel and detected the content of nickel.
- 3. a kind of nickel-IgE chelates as claimed in claim 1 are preparing the reagent for detecting nickel-IgE chelates in blood sample or examination Application in agent box.
- 4. a kind of comprise at least kit of the nickel-IgE chelates as claimed in claim 1 as standard items.
- 5. kit according to claim 4, it is characterised in that also including coating buffer, the coating buffer contains capture IgE's Material or the material for capturing nickel.
- A kind of 6. method for quantitatively detecting nickel-IgE chelates, it is characterised in that with described in the claim 1 of known content Nickel-IgE chelates are detected as standard items using a pair of samples of following methods：ELISA, enzyme linked immunological and original Sub- absorption spectrum combined techniques, enzyme linked immunological and inductivity coupled plasma mass spectrometry combined techniques, purifying nickel-IgE chelates with it is enzyme-linked Immune combined techniques, purifying nickel-IgE chelates and atomic absorption spectrum combined techniques, purifying nickel-IgE chelates and inductive etc. Gas ions mass spectrum combined techniques, electrophoresis and enzyme linked immunological or atomic absorption spectrum or inductivity coupled plasma mass spectrometry combined techniques.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510411520.6A CN105004684B (en) | 2015-07-14 | 2015-07-14 | Nickel-IgE chelate as well as preparation method and application thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510411520.6A CN105004684B (en) | 2015-07-14 | 2015-07-14 | Nickel-IgE chelate as well as preparation method and application thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN105004684A CN105004684A (en) | 2015-10-28 |
| CN105004684B true CN105004684B (en) | 2018-04-03 |
Family
ID=54377437
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510411520.6A Expired - Fee Related CN105004684B (en) | 2015-07-14 | 2015-07-14 | Nickel-IgE chelate as well as preparation method and application thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105004684B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108593906B (en) * | 2018-04-27 | 2022-02-15 | 天津华科泰生物技术有限公司 | Metal ion labeled immunoreaction double-pulse detection method |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1994022490A1 (en) * | 1993-03-29 | 1994-10-13 | Immunomedics, Inc. | Conjugates of proteins and bifunctional ligands |
| CN101045748A (en) * | 2007-02-28 | 2007-10-03 | 中国人民解放军第二军医大学 | HIV protease substrate molecular with evolution immune globulin binding molecular, preparation method and application thereof |
| CN102115497A (en) * | 2009-12-30 | 2011-07-06 | 中国人民解放军第二军医大学 | Human IgA immunoglobulin combination molecule having intramolecular affinity effect |
| CN102399289A (en) * | 2011-10-21 | 2012-04-04 | 复旦大学 | Human IgE (immunoglobulin E) resisting antibody Fab fragment, encoding gene and application |
-
2015
- 2015-07-14 CN CN201510411520.6A patent/CN105004684B/en not_active Expired - Fee Related
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1994022490A1 (en) * | 1993-03-29 | 1994-10-13 | Immunomedics, Inc. | Conjugates of proteins and bifunctional ligands |
| CN101045748A (en) * | 2007-02-28 | 2007-10-03 | 中国人民解放军第二军医大学 | HIV protease substrate molecular with evolution immune globulin binding molecular, preparation method and application thereof |
| CN102115497A (en) * | 2009-12-30 | 2011-07-06 | 中国人民解放军第二军医大学 | Human IgA immunoglobulin combination molecule having intramolecular affinity effect |
| CN102399289A (en) * | 2011-10-21 | 2012-04-04 | 复旦大学 | Human IgE (immunoglobulin E) resisting antibody Fab fragment, encoding gene and application |
Non-Patent Citations (1)
| Title |
|---|
| 六价铬间接竞争ELISA检测试剂盒的研制及新型一步法竞争ELISA的建立;邹军辉;《中国优秀硕士学位论文全文数据库 医药卫生科技辑》;20121015(第10期);论文正文第13-16页 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN105004684A (en) | 2015-10-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105004684B (en) | Nickel-IgE chelate as well as preparation method and application thereof | |
| CN104987409B (en) | lead-IgG chelate as well as preparation method and application thereof | |
| CN105004685B (en) | Mercury-IgE chelate and preparation method and application thereof | |
| CN105044005B (en) | chromium-IgA chelate as well as preparation method and application thereof | |
| CN105004686B (en) | Chromium-albumin chelate as well as preparation method and application thereof | |
| CN105021549B (en) | Nickel-albumin chelate as well as preparation method and application thereof | |
| CN104987391B (en) | Mercury-albumin chelate and preparation method and application thereof | |
| CN105021548B (en) | Arsenic-fibrinogen chelate as well as preparation method and application thereof | |
| CN104987407B (en) | cadmium-IgG chelate as well as preparation method and application thereof | |
| CN105044006B (en) | Mercury-IgG chelate and preparation method and application thereof | |
| CN105044004B (en) | Mercury-IgM chelate as well as preparation method and application thereof | |
| CN105044007B (en) | cadmium-IgM chelate as well as preparation method and application thereof | |
| CN104987412A (en) | Arsenic-IgE chelate as well as preparation method and application thereof | |
| CN104987405B (en) | A kind of arsenic IgG chelates and its preparation method and application | |
| CN105004683B (en) | chromium-IgE chelate as well as preparation method and application thereof | |
| CN104987400A (en) | Mercury-hemoglobin chelate as well as preparation method and application thereof | |
| CN105021554B (en) | arsenic-IgM chelate as well as preparation method and application thereof | |
| CN105044009B (en) | Chromium-very low density lipoprotein chelate and preparation method and application thereof | |
| CN104987406A (en) | Nickel-IgA chelate as well as preparation method and application thereof | |
| CN105044008B (en) | Cadmium-high density lipoprotein chelate as well as preparation method and application thereof | |
| CN105021550B (en) | Mercury-high density lipoprotein chelate and preparation method and application thereof | |
| CN104987411A (en) | Cadmium-IgA chelate as well as preparation method and application thereof | |
| CN104987413A (en) | Arsenic-IgA chelate as well as preparation method and application thereof | |
| CN105021552B (en) | Nickel-high density lipoprotein chelate as well as preparation method and application thereof | |
| CN104987403A (en) | Nickel-hemoglobin chelate as well as preparation method and application thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20210419 Address after: Room 3787, 3rd floor, No.22 GUANGTANG West Road, Tianhe District, Guangzhou, Guangdong 510630 Patentee after: Guangzhou Jinhai Health Technology Co.,Ltd. Address before: 200000, Shanghai, Pudong New Area, China (Shanghai) free trade zone, new Jinqiao Road, No. 13, building 27, 2 floor Patentee before: SHANGHAI BAIHAO BIOTECHNOLOGY Co.,Ltd. |
|
| TR01 | Transfer of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20180403 Termination date: 20210714 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |